tiprankstipranks
Advertisement
Advertisement

IPSC Stock Latest News

Century Therapeutics Shareholders Approve Directors and Share Increase
Company AnnouncementsCentury Therapeutics Shareholders Approve Directors and Share Increase
20d ago
8K
IPSC
Century Therapeutics presents new preclinical data for CNTY-813
PremiumThe Fly
Century Therapeutics presents new preclinical data for CNTY-813
24d ago
IPSC
Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy
PremiumCompany Announcements
Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy
24d ago
8K
IPSC
Century Therapeutics initiated with an Outperform at Mizuho
PremiumThe Fly
Century Therapeutics initiated with an Outperform at Mizuho
1M ago
IPSC
Century Therapeutics reports Q1 EPS (11c), consensus (17c)
PremiumThe Fly
Century Therapeutics reports Q1 EPS (11c), consensus (17c)
2M ago
IPSC
Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright
PremiumThe FlyCentury Therapeutics price target raised to $5 from $2 at H.C. Wainwright
2M ago
IPSC
Century Therapeutics Updates ATM Program to Enhance Liquidity
Premium
Company Announcements
Century Therapeutics Updates ATM Program to Enhance Liquidity
3M ago
8K
IPSC
Century Therapeutics Reports 2025 Results and Pipeline Progress
Premium
Company Announcements
Century Therapeutics Reports 2025 Results and Pipeline Progress
4M ago
8K
IPSC
Century Therapeutics reports FY25 EPS (14c), consensus (17c)
PremiumThe Fly
Century Therapeutics reports FY25 EPS (14c), consensus (17c)
4M ago
IPSC
IPSC Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
IPSC Upcoming Earnings Report: What to Expect?
4M ago
IPSC
Century Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
Century Therapeutics initiated with a Buy at TD Cowen
4M ago
IPSC
Century Therapeutics files to sell 176.09M shares of common stock for holders
PremiumThe Fly
Century Therapeutics files to sell 176.09M shares of common stock for holders
5M ago
IPSC
Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split
PremiumCompany AnnouncementsCentury Therapeutics Regains Nasdaq Compliance, Halts Reverse Split
5M ago
8K
IPSC
Century Therapeutics price target raised to $4 from $2 at Piper Sandler
Premium
The Fly
Century Therapeutics price target raised to $4 from $2 at Piper Sandler
5M ago
IPSC
Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies
Premium
Company Announcements
Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies
6M ago
8K
IPSC
Century Therapeutics price target lowered to $6.60 from $8 at Clear Street
PremiumThe Fly
Century Therapeutics price target lowered to $6.60 from $8 at Clear Street
6M ago
IPSC
Century Therapeutics Announces Oversubscribed $135 Million Financing
PremiumCompany Announcements
Century Therapeutics Announces Oversubscribed $135 Million Financing
6M ago
8K
IPSC
Century Therapeutics prices 117.4M shares at $1.15 in private placement
PremiumThe Fly
Century Therapeutics prices 117.4M shares at $1.15 in private placement
6M ago
IPSC
Century Therapeutics announces resignation of board member
PremiumCompany Announcements
Century Therapeutics announces resignation of board member
6M ago
8K
IPSC
Century Therapeutics Updates on Cell Therapy Advancements
PremiumCompany AnnouncementsCentury Therapeutics Updates on Cell Therapy Advancements
7M ago
8K
IPSC
Century Therapeutics Expands Board with New Appointments
Premium
Company Announcements
Century Therapeutics Expands Board with New Appointments
7M ago
8K
IPSC
Century Therapeutics appoints Lee, Murphy to board of directors
Premium
The Fly
Century Therapeutics appoints Lee, Murphy to board of directors
7M ago
IPSC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >